PEREGRINE PHARMACEUTICALS, INC. COMMON STOCK PURCHASE AGREEMENT 4,000,000 SHARES OF COMMON STOCK APRIL 5, 2006Common Stock Purchase Agreement • April 6th, 2006 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledApril 6th, 2006 Company Industry JurisdictionThis Common Stock Purchase Agreement (this “Agreement”) is made and entered into as of April 5, 2006 (the “Effective Date”), by and between Peregrine Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Double U Master Fund LP (the “Investor”).